BELLUS Health Inc.

TSX:BLU Stock Report

Market Cap: CA$2.5b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

BELLUS Health Management

Management criteria checks 2/4

BELLUS Health's CEO is Roberto Bellini, appointed in Jan 2010, he has a tenure of 13.42 years. His total yearly compensation is $5.88M , comprised of 6.6% salary and 93.4% bonuses, including company stock and options. He directly owns 1.42% of the company’s shares, worth CA$35.22M. The average tenure of the management team and the board of directors is 2.5 years and 13.5 years respectively.

Key information

Roberto Bellini

Chief executive officer

US$5.9m

Total compensation

CEO salary percentage6.6%
CEO tenure13.4yrs
CEO ownership1.4%
Management average tenure2.5yrs
Board average tenure13.5yrs

Recent management updates

Recent updates

BELLUS Health (TSE:BLU) Is In A Good Position To Deliver On Growth Plans

Jan 16
BELLUS Health (TSE:BLU) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About BELLUS Health's (TSE:BLU) Cash Burn Situation

Sep 07
Here's Why We're Not Too Worried About BELLUS Health's (TSE:BLU) Cash Burn Situation

We're Hopeful That BELLUS Health (TSE:BLU) Will Use Its Cash Wisely

May 05
We're Hopeful That BELLUS Health (TSE:BLU) Will Use Its Cash Wisely

Here's Why We're Watching BELLUS Health's (TSE:BLU) Cash Burn Situation

Jan 06
Here's Why We're Watching BELLUS Health's (TSE:BLU) Cash Burn Situation

Companies Like BELLUS Health (TSE:BLU) Are In A Position To Invest In Growth

Sep 10
Companies Like BELLUS Health (TSE:BLU) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Roberto Bellini's remuneration changed compared to BELLUS Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$87m

Dec 31 2022US$6mUS$389k

-US$76m

Sep 30 2022n/an/a

-US$73m

Jun 30 2022n/an/a

-US$71m

Mar 31 2022n/an/a

-US$70m

Dec 31 2021US$2mUS$327k

-US$71m

Sep 30 2021n/an/a

-US$64m

Jun 30 2021n/an/a

-US$47m

Mar 31 2021n/an/a

-US$37m

Dec 31 2020US$3mUS$299k

-US$32m

Sep 30 2020n/an/a

-US$34m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$33m

Dec 31 2019US$2mUS$280k

-US$26m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$14m

Mar 31 2019n/an/a

-US$9m

Dec 31 2018US$568kUS$206k

-US$7m

Sep 30 2018n/an/a

-US$6m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$4m

Dec 31 2017US$622kUS$253k

-US$1m

Sep 30 2017n/an/a

-US$613k

Jun 30 2017n/an/a

US$234k

Mar 31 2017n/an/a

-US$219k

Dec 31 2016US$288kUS$266k

-US$2m

Compensation vs Market: Roberto's total compensation ($USD5.88M) is above average for companies of similar size in the Canadian market ($USD2.47M).

Compensation vs Earnings: Roberto's compensation has increased whilst the company is unprofitable.

CEO

Roberto Bellini (43 yo)

13.4yrs

Tenure

US$5,884,787

Compensation

Mr. Roberto Francesco Bellini has been the Chief Executive Officer and President of BELLUS Health Inc, since January 1, 2010. Mr. Bellini served as an Executive Vice President of Picchio Pharma Inc. until...

Leadership Team

NamePositionTenureCompensationOwnership
Roberto Bellini
President13.4yrsUS$5.88m1.42%
$ 35.2m
Ramzi Benamar
Chief Financial Officer2.5yrsUS$1.67mno data
Andreas Orfanos
Chief Operating Officer1.2yrsUS$2.51mno data
Denis Garceau
Chief Scientific Officer2yrsUS$1.52m0.25%
$ 6.2m
Catherine Bonuccelli
Chief Medical Officer3.8yrsUS$1.76mno data
Daniel Matthews
Director of Investor Relations & Communicationsno datano datano data
Tony Matzouranis
Chief Business Officer2yrsUS$626.31k0.13%
$ 3.1m
Sebastien Roy
Corporate Secretary12.3yrsno datano data

2.5yrs

Average Tenure

50yo

Average Age

Experienced Management: BLU's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Roberto Bellini
President14.4yrsUS$5.88m1.42%
$ 35.2m
Francesco Bellini
Chairman of the Board21.4yrsUS$752.59k0.35%
$ 8.6m
Franklin Berger
Independent Director13.1yrsUS$367.33k0.55%
$ 13.6m
Joseph Rus
Independent Director14yrsUS$341.85k0.047%
$ 1.2m
Clarissa Desjardins
Independent Director5.8yrsUS$271.94k0.082%
$ 2.0m
Youssef Bennani
Independent Director6.1yrsUS$286.17k0.13%
$ 3.1m
Pierre Larochelle
Independent Lead Director14yrsUS$550.99k0.18%
$ 4.6m
William Mezzanotte
Independent Director2.3yrsUS$253.58kno data

13.5yrs

Average Tenure

63yo

Average Age

Experienced Board: BLU's board of directors are seasoned and experienced ( 13.5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.